The first report of a gross deletion in the SCNN1G gene in a case presenting with hyponatremic convulsion at fifth year of treatment
Journal of Pediatric Endocrinology and Metabolism · 2025
DOI: 10.1515/jpem-2025-0372 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Pediatric Endocrinology and Metabolism, 2025. Verfasst von Leyla Gizem Bolaç Özyılmaz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Endocrinology, University of Health Sciences Şişli Hamidiye Etfal Health Practices and Research Centre, Istanbul, Türkiye. Hauptthemen laut MEDLINE: Hyponatremia, Pseudohypoaldosteronism, Epithelial Sodium Channels, Seizures. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Objectives
Systemic pseudohypoaldosteronism type 1(PHA1) is a rare, autosomal recessive disorder resulting from loss-of-function mutations in epithelial sodium channel subunit genes. These mutations lead to aldosterone resistance in multiple tissues and typically manifest as hyponatremia, hyperkalemia, and metabolic acidosis. Case presentation We report the case of a male infant with a history of severe neonatal hyponatremia and hyperkalemia. The case presented to our center with persistent electrolyte imbalances and treatment-resistant eczematous skin lesions. Initial sequencing of PHA1-associated genes (SCNN1A, SCNN1B, and SCNN1G) did not reveal any pathogenic variants. At the age of five, the case experienced a febrile seizure, during which laboratory related biochemical tests showed isolated hyponatremia with normokalemia. Further genetic work-up with high-resolution chromosomal microarray analysis was performed, revealing a novel homozygous gross deletion involving exons 2–3 of the SCNN1G gene.
Conclusions
This is the first reported case of a homozygous gross deletion in the SCNN1G gene. This case expands the phenotypic and genotypic spectrum of systemic PHA1 and emphasizes the importance of considering copy number variants in genetically unresolved cases of PHA1, especially those presenting with atypical electrolyte profiles and extrarenal manifestations such as persistent eczema.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Endocrinology, University of Health Sciences Şişli Hamidiye Etfal Health Practices and Research Centre, Istanbul, Türkiye.
- Department of Medical Genetics, Faculty of Medicine, Karadeniz Technical University, Trabzon, Türkiye.
ORCID-Profile: Leyla Gizem Bolaç Özyılmaz, Ayberk Türkyılmaz, Özge Pelin Akbay, Aydilek Dağdeviren Çakır, Ahmet Uçar
Zitieren
APA
Bolaç Özyılmaz, L. G., Türkyılmaz, A., Akbay, Ö. P., Çakır, A. D., & Uçar, A. (2025). The first report of a gross deletion in the SCNN1G gene in a case presenting with hyponatremic convulsion at fifth year of treatment. Journal of Pediatric Endocrinology and Metabolism. https://doi.org/10.1515/jpem-2025-0372
Vancouver
Bolaç Özyılmaz LG, Türkyılmaz A, Akbay ÖP, Çakır AD, Uçar A. The first report of a gross deletion in the SCNN1G gene in a case presenting with hyponatremic convulsion at fifth year of treatment. Journal of Pediatric Endocrinology and Metabolism. 2025. doi:10.1515/jpem-2025-0372
BibTeX
@article{Bolazylmaz2025,
author = {Bolaç Özyılmaz, Leyla Gizem and Türkyılmaz, Ayberk and Akbay, Özge Pelin and Çakır, Aydilek Dağdeviren and Uçar, Ahmet},
title = {The first report of a gross deletion in the SCNN1G gene in a case presenting with hyponatremic convulsion at fifth year of treatment},
journal = {Journal of Pediatric Endocrinology and Metabolism},
year = {2025},
doi = {10.1515/jpem-2025-0372}
}
EUVIMED